Cannabidiol patent applications http://tgs.freshpatents.com/Cannabidiol-bx1.php The latest patent applications on FreshPatents.com related to Cannabidiol en-us Tue, 21 Oct 2014 19:47:54 -0700 1000 FreshPatents.com: Recent Cannabidiol patent applications 141 31 http://tgs.freshpatents.com/Cannabidiol-bx1.php http://www.freshpatents.com/images/freshpatentsnav_rss.gif Pharmaceutical composition comprising cannabinoids having reduced psychoactivity through the combination of cbd and non-decarboxylated thc http://www.freshpatents.com/-dt20141009ptan20140302086.php Fri, 10 Oct 2014 00:00:00 -0700 The present invention relates to a pharmaceutical composition comprising non-decarboxylated Δ9 Tetrahydrocannabinol (THC), Cannabidiol (CBD), and at least one small molecule selected from Citric Acid, Ascorbic Acid, Citrus Essential Oil(s), Lecithin, one or more sugar(s), Resvertrol, and combinations thereof, wherein the composition exhibits an increased but negated psychoactivity with concurrent enhancement... Anti-tumoural effects of cannabinoid combinations http://www.freshpatents.com/-dt20140925ptan20140287067.php Fri, 26 Sep 2014 00:00:00 -0700 The invention relates to the use of a combination of cannabinoids, particularly tetrahydrocannabinol (THC) and cannabidiol (CBD), in the manufacture of a medicament for use in the treatment of cancer. In particular the cancer to be treated is a brain tumour, more particularly a glioma, more particularly still a glioblastoma multiforme... Cannabis plant named 'avidekel' http://www.freshpatents.com/-dt20140911ptan20140259228.php Fri, 12 Sep 2014 00:00:00 -0700 The disclosure relates to a new and distinct cultivar of Cannabis Sativa plant named ‘Avidekel’, characterized by a high amount of Cannabidiol (CBD) (16.3%) and a very low amount of Tetrahydrocannabinol (THC, 0.8%).... Cannabis plant named 'avidekel' http://www.freshpatents.com/-dt20140911ptan20140259228.php Fri, 12 Sep 2014 00:00:00 -0700 The disclosure relates to a new and distinct cultivar of Cannabis Sativa plant named ‘Avidekel’, characterized by a high amount of Cannabidiol (CBD) (16.3%) and a very low amount of Tetrahydrocannabinol (THC, 0.8%).... Process for producing an extract containing tetrahydrocannabinol and cannabidiol from cannabis plant material, and cannabis extracts http://www.freshpatents.com/-dt20140904ptan20140248379.php Fri, 05 Sep 2014 00:00:00 -0700 The invention relates to a method for producing an extract from cannabis plant matter, containing tetrahydrocannabinol, cannabidiol and optionally the carboxylic acids thereof. According to said method, the dried pint matter is ground and subjected to a CO2 extraction and the primary extract obtained is separated. The invention method permits Δ8... A pharmaceutical composition comprising the phytocannabinoids cannabidivarin (cbdv) and cannabidiol (cbd) http://www.freshpatents.com/-dt20140828ptan20140243405.php Fri, 29 Aug 2014 00:00:00 -0700 This invention relates to a pharmaceutical composition comprising or consisting essentially of the phytocannabinoids cannabidivarin (CBDV) and cannabidiol (CBD). The composition is particularly safe and efficacious for use in the treatment of neurological conditions, characterized by hyper-excitability of the central nervous system, convulsions or seizures such as occur in epilepsy. Preferably... Cannabis plant named erez http://www.freshpatents.com/-dt20140828ptan20140245494.php Fri, 29 Aug 2014 00:00:00 -0700 The disclosure relates to a new and distinct cultivar of Cannabis Sativa plant named ‘Erez’, characterized by a high amount of Cannabidiol (CBD) (>16%) and a higher amount of Tetrahydrocannabinol (THC, ˜23%).... Cannabis plant named midnight http://www.freshpatents.com/-dt20140828ptan20140245495.php Fri, 29 Aug 2014 00:00:00 -0700 The disclosure relates to a new and distinct Cannabis Sativa L. plant named ‘Midnight’, having an almost equal ratio of Cannabidiol (CBD) concentration to Tetrahydrocannabinol (THC) concentration, (e.g., substantially close to 1), as illustrated and described herein.... Phytocannabinoids for use in the treatment of cancer http://www.freshpatents.com/-dt20140807ptan20140221469.php Fri, 08 Aug 2014 00:00:00 -0700 The present invention relates to the use of phytocannabinoids in the treatment of cancer. More particularly it relates to the use of phytocannabinoids in the treatment of tumour cell invasion and cell migration or metastases. Cancers, where invasion and cell migration plays a key role in prognosis include brain tumours, more... Smokeless thc and administration method thereof http://www.freshpatents.com/-dt20140731ptan20140209109.php Fri, 01 Aug 2014 00:00:00 -0700 A pharmaceutical composition and administration apparatus includes a portable powered vaporizer with a mouthpiece, smokeless vaporizing element, and a removable chamber. The chamber contains a composition comprising tetrahydrocannabinol (THC), cannabidiol (CBD), FCC grade ethanol, flavoring, pharmaceutical grade nicotine, USP grade aqueous glycerine, USP/EP grade propylene glycol, and USP grade vegetable glycerine.... Enhanced delivery of nicotine, thc, tobacco, cannabidiol or base alkaloid from an electronic cigarette or other vapor producing device through use of an absorption conditioning unit http://www.freshpatents.com/-dt20140619ptan20140166027.php Fri, 20 Jun 2014 00:00:00 -0700 A method for the administration of nicotine, THC, tobacco, cannabidiol or a base alkaloid includes administering an absorption conditioning unit having at least two agents selected from the group consisting of (a) a buffer agent, (b) a capturing agent, (c) a penetration agent, and (d) a thermal agent, to the mammal,... Enhanced delivery of nicotine, thc, tobacco, cannabidiol or base alkaloid from an electronic cigarette or other vapor or smoke producing device through use of an absorption conditioning unit http://www.freshpatents.com/-dt20140619ptan20140166028.php Fri, 20 Jun 2014 00:00:00 -0700 A method for the administration of nicotine, THC, tobacco, cannabidiol or a base alkaloid includes administering in the oral or nasal cavity an absorption conditioning unit having at least two agents selected from the group consisting of (a) a buffer agent, (b) a capturing agent, (c) a penetration agent, and (d)... Use of the phytocannabinoid cannabidiol (cbd) in combination with a standard anti-epileptic drug (saed) in the treatment of epilepsy http://www.freshpatents.com/-dt20140605ptan20140155456.php Fri, 06 Jun 2014 00:00:00 -0700 The invention relates to the use of cannabidiol (CBD), at a dose of greater than 300 mg/day, in combination with a standard anti-epileptic drug (SAED) which acts via sodium or calcium channels, for use in the treatment of epilepsy. The SAED is preferably one which•modifies low-threshold or transient neuronal calcium currents,or•reduces... Methods and compositions for treating cancer http://www.freshpatents.com/-dt20140306ptan20140065243.php Fri, 07 Mar 2014 00:00:00 -0800 This disclosure provides compositions and method useful for treating cell proliferative disorders including cancer. The disclosure provides cannabidiol derivatives and compositions thereof either alone or in combination with THC or a derivative thereof.... System and method of reducing impairment of alertness, concentration, motivation, and creativity caused by medication http://www.freshpatents.com/-dt20131219ptan20130337052.php Fri, 20 Dec 2013 00:00:00 -0800 Administering a therapeutically effective dose of lithium ions mitigates the side effects of a psychoactive substance such as a cannabinoid. The therapeutically effective dose of lithium ions includes greater than 4 milligrams of lithium and less than 170 milligrams of lithium, or includes between 8 and 32 milligrams of lithium ions... Use of the phytocannabinoid cannabidiol (cbd) in combination with a standard anti-epileptic drug (saed) in the treatment of epilepsy http://www.freshpatents.com/-dt20131107ptan20130296398.php Fri, 08 Nov 2013 00:00:00 -0800 The invention relates to the use of cannabidiol (CBD), at a dose of greater than 300 mg/day, in combination with a standard anti-epileptic drug (SAED) which acts via sodium or calcium channels, for use in the treatment of epilepsy. The SAED is preferably one which•modifies low-threshold or transient neuronal calcium currents,or•reduces... Use of cannabidiol in the treatment of hepatitis http://www.freshpatents.com/-dt20121129ptan20120302646.php Fri, 30 Nov 2012 00:00:00 -0800 Cannabinoids are known to interact with CB1 and CB2 receptors expressed in the nervous and immune systems mediating a wide range of effects, including anti-inflammatory properties. However, cannabinoids that bind CB1 are also psychoactive thereby limiting their clinical use. Cannabidiol (CBD) is the most abundant nonpsychotropic plant cannabinoid but has not... Pharmaceutical composition comprising cannabinoids http://www.freshpatents.com/-dt20121122ptan20120295968.php Fri, 23 Nov 2012 00:00:00 -0800 The present invention relates to a pharmaceutical composition comprising Δ9 Tetrahydrocannabinol (THC), Cannabidiol (CBD), and at least one small molecule selected from Citric Acid, Ascorbic Acid, Citrus Essential Oil(s), Lecithin, one or more sugar(s), Resvertrol, and combinations thereof, wherein the composition exhibits an increased but negated psychoactivity with concurrent enhancement in... Cannabinoids for use in the treatment of neuropathic pain http://www.freshpatents.com/-dt20120927ptan20120245224.php Fri, 28 Sep 2012 00:00:00 -0700 The present invention relates to the use of cannabidiol (CBD) type compounds or derivative thereof and tetrahydrocannabinol (THC) type compounds or derivative thereof in the manufacture of a medicament for the treatment of neuropathic pain. Preferably, the ratio of the CBD type compounds or derivative thereof and THC type compounds or... Transdermal delivery of cannabinoids http://www.freshpatents.com/-dt20120209ptan20120034293.php Fri, 10 Feb 2012 00:00:00 -0800 The present invention overcomes the problems associated with existing drug delivery systems by delivering cannabinoids transdermally. Preferably, the cannabinoids are delivered via an occlusive body (i.e., a patch) to alleviate harmful side effects and avoid gastrointestinal (first-pass) metabolism of the drug by the patient. A first aspect of the invention provides...